U.S. markets closed

Calithera Biosciences, Inc. (CALA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9010+0.0130 (+1.46%)
At close: 1:00PM EST
0.8938 -0.01 (-0.80%)
After hours: 04:58PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close0.8880
Bid0.8877 x 1200
Ask0.8938 x 800
Day's Range0.8600 - 0.9159
52 Week Range0.8100 - 6.1850
Avg. Volume1,636,112
Market Cap67.508M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-0.9410
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CALA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Calithera Biosciences, Inc.
    Weekly Stock ListVickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional ownership trends. Form 13-Fs are due 45 days after the end of calendar quarters, and have now come in from 2Q21. We like to review the 13Fs of the major activist investors, including Carl Icahn, Trian Fund Management, Jana Partners, and ValueAct Holdings, among others. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Here are some recent new purchases and key holdings of activist investors, according to Vickers.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • InvestorPlace

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

    Good morning, investor! We’re getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday! Source: ventdusud / Earnings reports, IPOs, acquisition news, and more have stocks moving during this morning’s pre-market trading. Let’s dive into those pre-market stock movers below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-Market Stock Movers: 10 Top Gainers Sono Group (NASDAQ:SEV) stock is soaring more than 27% after

  • GlobeNewswire

    Calithera to Present at the 2021 Jefferies London Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the company’s founder, president and chief executive officer, will present at the 2021 Jefferies London Healthcare Conference. The presentation will be available for on-demand viewing starting Thursday, November 18 at 3:00 a.m. Eastern Time, and can be accessed through the Investors

  • Benzinga

    Calithera Biosciences Insider Trades $170K In Company Stock

    Jonathan G Drachman, Insider at Calithera Biosciences (NASDAQ:CALA), made a large insider buy on November 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Drachman purchased 200,000 shares of Calithera Biosciences at $0. Drachman now owns a total of 200,000 of Calithera Biosciences worth, 177,260. Calithera Biosciences shares are trading up 6.55% at $0.89 at the time of this writing on Thursday morning. No